Metal Deficit in Mouse Brain Plaques Guides Direction of Human Alzheimer's Disease Research

November 4, 2009 by Kendra Snyder,
(A) Thioflavin S-stained PSAPP mouse brain tissue. X-ray fluorescence microprobe images of (B) Zn, (C) Cu, (D) Fe, and (E) Ca distribution in the same tissue. (F) XRF microprobe spectra collected from the areas marked with asterisks in (A) - (E), comparing the center of a plaque (black) to the surrounding tissue (red). All scale bars are 5 µm.

( -- Minuscule plaques in the brains of mice with Alzheimer's disease contain much less metal than the brains of affected humans, according to a study conducted at the NSLS. This surprising finding could help researchers pinpoint the effect of metal in the human disease, and, in the long term, lead to targets for drug development or prevention methods.

One of the hallmark features of Alzheimer's diseased brain is (Aβ) plaques, small areas of dense built-up proteins named after a protein they contain. Many scientists believe that these plaques are involved in neurodegeneration - the destruction of brain cells that gradually destroys a person's ability to learn, reason, communicate, and carry out daily activities.

In previous studies, researchers have found an abundance of zinc, copper, and iron in the amyloid plaques in human Alzheimer's disease. These are essential to brain function and present in the body under normal conditions, but elevated levels in the plaques may catalyze the formation of free radicals, which are toxic to cells. In studies on mice that were bred to develop Aβ plaques, though, researchers have observed a discrepancy.

"Although the mice are designed to develop one of the features of Alzheimer's disease, they don't show severe neurodegeneration, memory deficits, or any of the other terrible things that are associated with human Alzheimer's disease," said Stony Brook University graduate student Andreana Leskovjan. That difference might be attributed to a lower concentration of metal in mouse Aβ plaques.

To investigate the possibility that metals might be the cause of one of the disease's most debilitating symptoms, Leskovjan and her research advisor, Lisa Miller worked with University of Chicago scientist Tony Lanzirotti to examine the metal content of mouse Aβ plaques.

The researchers used an x-ray fluorescence microscope at NSLS beamline X26A to determine the metal concentration in plaques and surrounding non-plaque tissue taken from mice representing end-stage Alzheimer's disease. Fourier transform infrared microspectroscopy at beamline U10B also was used to normalize the data for the amount of protein in each . They then compared the metal levels to previously collected data taken from human brains.

Their results were surprising, but important for the Alzheimer's research field, Leskovjan said. In mice, the plaques only showed an elevation in one type of metal - zinc, up by 29 percent - as compared to the surrounding tissue. But the mouse plaques actually had less copper and iron (about a 22 percent and 17 percent decrease, respectively) than in the surrounding tissue. Human Aβ plaques, by comparison, showed a 339 percent increase in zinc, a 466 percent increase in copper, and a 177 percent increase in iron.

Their results were published in the October 1, 2009 edition of the journal NeuroImage.

"Even though the mice don't match the human results, this study provides some very valuable information," Leskovjan said. "The metal deficit in mice could actually help us narrow down what's happening in the brains of human Alzheimer's disease patients. For instance, maybe the abundance of copper and iron, which aren't present in mice, could be causing the neurodegeneration that's seen in humans."

The mice only provide a limited representation of the human disease, and differences in plaques could be due to a number of factors between the two species, but this study provides a solid path to follow, Leskovjan said.

If metals turn out to be the culprit, further research might lead to the identification of targets for drug development or metal-targeted therapy to remove the excess metals from the plaques.

Now, the researchers are studying the metal concentrations in early-stage Aβ mouse plaques to determine how age affects the levels.

More information: A.C. Leskovjan, A. Lanzirotti, L.M. Miller, "Amyloid Plaques in PSAPP Bind Less Metal Than Plaques in Human ," NeuroImage, 47(4), 1215-1220 (2009).

Provided by Brookhaven National Laboratory (news : web)

Related Stories

Recommended for you

Even without nudging blood pressure up, high-salt diet hobbles the brain

January 16, 2018
A high-salt diet may spell trouble for the brain—and for mental performance—even if it doesn't push blood pressure into dangerous territory, new research has found.

Brain imaging predicts language learning in deaf children

January 15, 2018
In a new international collaborative study between The Chinese University of Hong Kong and Ann & Robert H. Lurie Children's Hospital of Chicago, researchers created a machine learning algorithm that uses brain scans to predict ...

Preterm babies may suffer setbacks in auditory brain development, speech

January 15, 2018
Preterm babies born early in the third trimester of pregnancy are likely to experience delays in the development of the auditory cortex, a brain region essential to hearing and understanding sound, a new study reveals. Such ...

BOLD view of white matter

January 15, 2018
The brain consists of gray matter, which contains the nerve cell bodies (neurons), and white matter, bundles of long nerve fibers (axons) that until recently were considered passive transmitters of signals between different ...

Does an exploding brain network cause chronic pain?

January 12, 2018
A new study finds that patients with fibromyalgia have brain networks primed for rapid, global responses to minor changes. This abnormal hypersensitivity, called explosive synchronization (ES), can be seen in other network ...

An innovative PET tracer can measure damage from multiple sclerosis in mouse models

January 12, 2018
The loss or damage of myelin, a cellular sheath that surrounds and insulates nerves, is the hallmark of the immune-mediated neurological disorder multiple sclerosis (MS). When segments of this protective membrane are damaged, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.